Delta-like Ligand 1 For Diagnosing Severe Infections

  • Published: May 1, 2019
  • Earliest Priority: Oct 25 2017
  • Family: 2
  • Cited Works: 6
  • Cited by: 0
  • Cites: 8
  • Additional Info: Cited Works
Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The invention refers to a method for in vitro diagnosis and/or prognosis of a severe infection comprising determining delta-like ligand 1 protein or a nucleotide sequence coding for delta-like ligand 1 protein in a biological sample wherein an elevated level of expression of delta-like ligand 1 protein or a nucleotide sequence coding for delta-like ligand 1 protein is indicative of a severe infection; and the use of delta-like ligand 1 protein as a biomarker for in vitro diagnosis and/or prognosis of a severe infection such as sepsis.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: May 1, 2019
  • Application: Oct 25, 2017
    EP EP 17198330 A
  • Priority: Oct 25, 2017
    EP EP 17198330 A

Download Citation


Sign in to the Lens

Feedback